Cargando…

Semaphorin 3A, a potential immune regulator in Familial Mediterranean Fever

Detalles Bibliográficos
Autores principales:	Rimar, D, Rosner, I, Slobodin, G, Boulman, N, Kaly, L, Rozenbaum, M, Vadasz, Z
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Oral Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4597259/ http://dx.doi.org/10.1186/1546-0096-13-S1-O46

Ejemplares similares

Ulcerative Colitis and Familial Mediterranean Fever: Can Anakinra Treat Both?
por: Kaly, Lisa, et al.
Publicado: (2019)

P01-009 – 2 years of colchicine IV in intractable FMF
por: Kaly, L, et al.
Publicado: (2013)

Tocilizumab Efficacy in a Patient with Positive Anti-CCP Chronic Lyme Arthritis
por: Hirsch, Julianna, et al.
Publicado: (2016)

Q Fever Risk in Patients Treated with Chronic Antitumor Necrosis Factor-Alpha Therapy
por: Hirsch, Julianna, et al.
Publicado: (2016)

Radionuclide Methods in the Diagnosis of Sacroiliitis in Patients with Spondyloarthritis: An Update
por: Zilber, Karina, et al.
Publicado: (2016)

Giant Cell Arteritis: State of the Art in Diagnosis, Monitoring, and Treatment
por: Awisat, Abid, et al.
Publicado: (2023)

P01-010 – Anti-TNF agents in intractable FMF: four cases
por: Kaly, L, et al.
Publicado: (2013)

Variant CAPS in an adult- the use of genetics
por: Rozenbam, M, et al.
Publicado: (2015)

Regulation of immune cell responses by semaphorins and their receptors
por: Kumanogoh, Atsushi, et al.
Publicado: (2012)

Canakinumab therapy in patients with Familial Mediterranean Fever
por: Ugurlu, S, et al.
Publicado: (2015)

Pulmonary hypertension in familial Mediterranean fever: consequence or coincidence?
por: Sargsyan, A, et al.
Publicado: (2015)

Familial Mediterranean Fever in childhood: a single center experience
por: Barut, K, et al.
Publicado: (2015)

Investigation of the inflammatory cell migration process in familial Mediterranean fever
por: Ulum, YZ Akkaya, et al.
Publicado: (2015)

Unified modeling of Familial Mediterranean Fever and Cryopyrin Associated Periodic Syndromes
por: Gul, A, et al.
Publicado: (2015)

Semaphorin 3A is a marker for disease activity and a potential immunoregulator in systemic lupus erythematosus
por: Vadasz, Zahava, et al.
Publicado: (2012)

Endothelial biomarkers in patients with familial Mediterranean fever associated vascular disease and vasculopathy
por: Sargsyan, Y, et al.
Publicado: (2015)

Differential expression of miR-4520a is associated with gain of function mutations in Familial Mediterranean Fever (FMF)
por: Latsoudis, H, et al.
Publicado: (2015)

Rilonacept (IL-1 TRAP) for treatment of colchicine resistant familial mediterranean fever (FMF): a randomized, multicenter double-blinded, alternating treatment trial
por: Hashkes, PJ, et al.
Publicado: (2011)

Deletion in MEFV resulting in the loss of p.M694 residue as the cause of autosomal dominant familial Mediterranean fever in North Western European Caucasians - a case series and genetic exploration
por: Rowczenio, D, et al.
Publicado: (2015)

Familial Mediterranean Fever in older children
por: Özdel, Semanur, et al.
Publicado: (2014)

The role of genotype in Familial Mediterranean Fever
por: Özdel, Semanur, et al.
Publicado: (2014)

Comorbidities in patients with Familial Mediterranean Fever
por: Balci-Peynircioğlu, B, et al.
Publicado: (2015)

Neonatal onset Familial Mediterranean Fever
por: Özçakar, ZB, et al.
Publicado: (2015)

Illegal waste sites as potential micro foci of Mediterranean Leishmaniasis
por: Ivović, V, et al.
Publicado: (2014)

The association of Familial Mediterranean Fever and cryptogenic cirrhosis
por: Baskin, E, et al.
Publicado: (2008)

Musculoskeletal complaints in patients with Familial Mediterranean Fever
por: Özçakar, ZB, et al.
Publicado: (2015)

Familial Mediterranean Fever associated diseases in children
por: Özçakar, ZB, et al.
Publicado: (2015)

Articular involvement in childhood Familial Mediterranean Fever
por: Barut, K, et al.
Publicado: (2015)

Quality of life in children with familial Mediterranean fever
por: Öztürk, Ö, et al.
Publicado: (2015)

Familial Mediterranean Fever and Human autoinflammatory diseases
por: Hovhannisyan, L
Publicado: (2015)

Familial Mediterranean Fever (FMF) before the age of one year
por: Delion, F, et al.
Publicado: (2008)

Truncated-semaphorin3A is a potential regulatory molecule to restore immune homeostasis in immune-mediated diseases
por: Eiza, Nasren, et al.
Publicado: (2023)

Challenging case of Familial Mediterranean Fever and its management
por: Al Hosani, A, et al.
Publicado: (2015)

Increased frequency of psoriasis in the families of subjects with childhood Familial Mediterranean Fever
por: Barut, Kenan, et al.
Publicado: (2014)

The Involvement of Immune Semaphorins in the Pathogenesis of Inflammatory Bowel Diseases (IBDs)
por: Vadasz, Zahava, et al.
Publicado: (2015)

Adrenomedullin levels in patients with Familial Mediterranean Fever: a long term follow-up
por: Polat, A, et al.
Publicado: (2015)

Risk factors for subclinical inflammation in children with familial mediterranean fever
por: Soylu, Alper, et al.
Publicado: (2014)

Evidence based recommendations for genetic diagnosis of Familial Mediterranean Fever
por: Giancane, Gabriella, et al.
Publicado: (2014)

Screening for inherited metabolic disorders in patients with Familial Mediterranean Fever
por: Kiykim, E, et al.
Publicado: (2015)

L-ficolin and H-ficolin in patients with Familial Mediterranean fever
por: Mkrtchyan, G, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_5tna030qgpdfuneu11oqkle5cq